Expert Insights on Managing Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Dr. Dorritie shares her expertise on the management of untreated and relapsed/refractory CLL, highlighting the…
Oncology
Unlocking the Potential of Targetable Mutations in GIST: A Breakthrough in Cancer Treatment
Recent advancements in the field of oncology have highlighted the significance of targetable mutations in…
Breakthroughs in Multiple Myeloma Treatment: Cilta-cel and Ide-cel
Experts discuss the real-world roles of cilta-cel and ide-cel in treating relapsed or refractory multiple…
Tabelecleucel Under Review for EBV Post-Transplant Lymphoproliferative Disease Treatment
Tabelecleucel, an investigational treatment, is under review for the treatment of Epstein-Barr virus (EBV) post-transplant…
Pediatric-Inspired Regimens Show Promise in AYA and Adult ALL Treatment
Researchers are exploring the use of pediatric-inspired regimens in the treatment of acute lymphoblastic leukemia…
Monitoring for Interstitial Lung Disease in HER2-Positive Breast Cancer Patients Receiving T-DXd
Experts discuss the importance of monitoring for interstitial lung disease in patients with HER2-positive breast…
Breakthrough in MPDAC Treatment: BXCL701 and Pembrolizumab Combination Shows Promising Results
A recent study has revealed the potential of combining BXCL701 with pembrolizumab in treating metastatic…